Does APIXABAN Cause Activated partial thromboplastin time prolonged? 86 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 86 reports of Activated partial thromboplastin time prolonged have been filed in association with APIXABAN (ELIQUIS). This represents 0.1% of all adverse event reports for APIXABAN.
86
Reports of Activated partial thromboplastin time prolonged with APIXABAN
0.1%
of all APIXABAN reports
4
Deaths
41
Hospitalizations
How Dangerous Is Activated partial thromboplastin time prolonged From APIXABAN?
Of the 86 reports, 4 (4.7%) resulted in death, 41 (47.7%) required hospitalization, and 10 (11.6%) were considered life-threatening.
Is Activated partial thromboplastin time prolonged Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APIXABAN. However, 86 reports have been filed with the FAERS database.
What Other Side Effects Does APIXABAN Cause?
Death (18,501)
Cerebrovascular accident (7,237)
Atrial fibrillation (5,690)
Off label use (5,590)
Thrombosis (5,298)
Fall (5,063)
Cardiac disorder (4,917)
Haemorrhage (4,770)
Dyspnoea (4,379)
Gastrointestinal haemorrhage (4,030)
What Other Drugs Cause Activated partial thromboplastin time prolonged?
DABIGATRAN ETEXILATE (264)
HEPARIN (225)
RIVAROXABAN (163)
WARFARIN (146)
ACETAMINOPHEN (119)
ALLOPURINOL (110)
AMIODARONE (99)
METRONIDAZOLE (98)
SIMVASTATIN (94)
DARBEPOETIN ALFA (93)
Which APIXABAN Alternatives Have Lower Activated partial thromboplastin time prolonged Risk?
APIXABAN vs APOMORPHINE
APIXABAN vs APRACLONIDINE
APIXABAN vs APREMILAST
APIXABAN vs APREPITANT
APIXABAN vs APROTININ